Related Experiment Videos
Drug testing: technical complications of a complex social issue
1Cabot Corporation, Waltham, Massachusetts 02254.
American Journal of Industrial Medicine
|January 1, 1989
Summary
Urinary drug testing in the workplace is common but has limitations. Test results indicate exposure, not addiction, and quality control issues can impact treatment and lead to legal challenges.
Area of Science:
- Occupational Health
- Forensic Toxicology
- Medical Ethics
Background:
- Substance abuse in the workplace can lead to increased accidents, absenteeism, and decreased productivity.
- Urinary drug testing is frequently employed in occupational settings to mitigate these risks.
- Despite its prevalence, accurately assessing the impact of drug abuse at work remains challenging.
Purpose of the Study:
- To review the analytical techniques, interpretation challenges, and legal/ethical considerations of workplace urinary drug testing.
- To highlight the importance of quality control in laboratory performance.
- To inform organizations about the ramifications before implementing drug-screening programs.
Main Methods:
- Review of common analytical techniques including thin-layer chromatography, immunoassays, and gas chromatography-mass spectrometry.
- Discussion of the limitations in interpreting screening test results.
- Examination of legal and ethical issues, including privacy rights and anti-discrimination laws.
Main Results:
- Screening tests (thin-layer chromatography, immunoassays) detect drug exposure, not necessarily addiction or abuse.
- Confirmatory testing using gas chromatography-mass spectrometry is recommended for positive screens.
- Lack of standardized quality control leads to variable laboratory performance, potentially affecting patient treatment.
- Legal challenges cite privacy and unreasonable search concerns.
Conclusions:
- Urinary drug testing results indicate exposure, necessitating careful interpretation.
- Quality control and standardization are critical for reliable laboratory results.
- Organizations must carefully consider the legal, ethical, and medical implications before implementing drug-screening programs.